
|Poll|January 27, 2023
Poll: How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Author(s)OT Staff Reports
Let us know how familiar are you on the approval process for biosimilar drugs compared with new drug applications to the FDA. The poll will be open until February 28, 2023.
Advertisement
How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
2
Ocular Therapeutix randomizes first patient in HELIOS-3
3
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
4
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
5


















































.png)


